DiaMedica Therapeutics (DMAC) Tax Rate (2018 - 2026)

DiaMedica Therapeutics' Tax Rate history runs 9 years deep, the most recent figure standing at 0.07% for Q1 2026.

• On a quarterly basis, Tax Rate rose 1.0% year-over-year to 0.07% in Q1 2026; TTM through Mar 2026 was 14.0%, a 1411.0% increase from a year earlier, with the FY2025 full-year figure at 15.0%, up 1512.0% from the prior year.
• Tax Rate retreated to 0.07% in Q1 2026 per DMAC's latest filing, from 56.46% in the prior quarter.
• Across five years, Tax Rate topped out at 56.46% in Q4 2025 and bottomed at 0.43% in Q4 2023.
• The 5-year median for Tax Rate is 0.14% (2024), against an average of 3.17%.
• Across the five-year window, Tax Rate slipped 24 bps in 2023 and soared 5657 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 0.19% in 2022, then plunged by 129 bps to 0.43% in 2023, then surged by 73 bps to 0.11% in 2024, then jumped by 49603 bps to 56.46% in 2025, then slumped by 100 bps to 0.07% in 2026.
• Per Business Quant, the three latest DMAC Tax Rate figures stand at 0.07% (Q1 2026), 56.46% (Q4 2025), and 0.07% (Q3 2025).